Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-20

Clinical Trial Update: Better Than Study: Targeting Heavy Alcohol Use With Naltrexone Among Men Who Have Sex With Men (MSM) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating naltrexone to reduce heavy alcohol use among men who have sex with men, including participants with HIV; results were posted in 2025-04…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone (Naltrexone)

Snippet

Sponsor: University of California, San Francisco | Conditions: Binge Drinking, HIV | Phase 2 | Status: COMPLETED | Results posted: 2025-04-20